These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 263655)

  • 1. Increased aldosterone plasma protein binding in women on combined oral contraceptives throughout the menstrual cycle.
    Nowaczynski W; Murakami T; Richardson K; Genest J
    J Clin Endocrinol Metab; 1978 Jul; 47(1):193-9. PubMed ID: 263655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of plasma aldosterone-binding globulin to blood pressure regulation in young adults with cystic fibrosis.
    Nowaczynski W; Nakielana EM; Murakami T; Shurmans J
    Clin Physiol Biochem; 1987; 5(5):276-86. PubMed ID: 3652602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral contraceptives on protein metabolism.
    Amatayakul K; Laokuldilok T; Koottathep S; Dejsarai W; Prapamontol T; Srirak N; Tansuhaj A; Uttaravichai C
    J Med Assoc Thai; 1994 Oct; 77(10):509-16. PubMed ID: 7745371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians.
    Nowaczynski W; Oliver WJ; Neel JV
    Clin Physiol Biochem; 1985; 3(6):289-306. PubMed ID: 3907928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple reproducible competitive radioligand assay for plasma protein binding of aldosterone.
    Nowaczynski W; Fung K; Wilkins GE
    Clin Physiol Biochem; 1985; 3(6):314-22. PubMed ID: 4075695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
    Jespersen J; Kluft C
    Thromb Haemost; 1986 Jun; 55(3):388-9. PubMed ID: 3092396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
    Schumacher M; Nanninga A; Delfs T; Mukhopadhyay AK; Leidenberger FA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):617-23. PubMed ID: 1639960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.
    Dibbelt L; Knuppen R; Kuhnz W; Jütting G
    Arzneimittelforschung; 1992 Sep; 42(9):1146-52. PubMed ID: 1445484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.